Form 4 for STAA STAAR SURGICAL CO
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001209191-21-055273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-09 | 2021-09-07 | STAA | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | S - Sale+OE | $157.40 | -40.7K | 77.2K | -34% | -$6.40M |
| DM | 2021-09-09 | 2021-09-07 | STAA | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | M - OptEx | $31.60 | +29.1K | 106.3K | +38% | +$920.5K |
| DM | 2021-09-09 | 2021-09-07 | STAA | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | M - OptEx | $0.00 | -29.1K | 16.9K | -63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | S | D | 11,522 | $157.40 | 77,200 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.45, inclusive. |
| 2 | Common | Common Stock | 2021-09-07 | M | A | 14,031 | $35.98 | 91,231 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-07 | M | A | 15,100 | $27.53 | 106,331 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-07 | S | D | 29,131 | $157.40 | 77,200 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.46, inclusive. |
| 5 | Derivative | Common Stock Options | 2021-09-07 | M | D | 14,031 | $0.00 | 4,109 | D | $35.98 · 2020-03-14 to 2029-03-13 | 14,031 Common Stock | (F3) The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029. |
| 6 | Derivative | Common Stock Options | 2021-09-07 | M | D | 15,100 | $0.00 | 16,879 | D | $27.53 · 2021-03-20 to 2030-03-19 | 15,100 Common Stock | (F4) The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the next 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023. |